| |
|
|
|
|
|
|
|||
|
Blood, 15 August 2007, Vol. 110, No. 4, pp. 1251-1261. Prepublished online as a Blood First Edition Paper on April 23, 2007; DOI 10.1182/blood-2006-12-064683.
NEOPLASIA The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children ois Sigaux1,21 Genome Rearrangements and Cancer Group, Institut National de la Santé et de la Recherche Médicale (INSERM) U728 and Institut Universitaire d'Hématologie, Paris 7 University, Hôpital Saint-Louis, Paris, France; 2 Hematology Laboratory, Assistance Publique Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Paris, France; 3 Laboratoire de Biochimie Génétique, APHP, Hôpital Robert Debré, Paris, France; 4 Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia; 5 Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; 6 Centre d'Immunologie de Marseille-Luminy, Université de la Méditerranée, Marseille, France; 7 Genomic Vision, Pasteur Biotop, Paris, France; 8 INSERM U509, Institut Curie-Section Recherche, Paris, France; 9 Pediatric Hematology Department, APHP, Hôpital Saint-Louis, Paris, France; 10 Adult Hematology Department, APHP, Hôpital Saint-Louis, Paris, France The C-Myb transcription factor is essential for hematopoiesis, including in the T-cell lineage. The C-Myb locus is a common site of retroviral insertional mutagenesis, however no recurrent genomic involvement has been reported in human malignancies. Here, we identified 2 types of genomic alterations involving the C-MYB locus at 6q23 in human T-cell acute leukemia (T-ALL). First, we found a reciprocal translocation, t(6;7)(q23;q34), that juxtaposed the TCRB and C-MYB loci (n = 6 cases). Second, a genome-wide copy-number analysis by array-based comparative genomic hybridization (array-CGH) identified short somatic duplications that include C-MYB (MYBdup, n = 13 cases of 84 T-ALL, 15%). Expression analysis, including allele-specific approaches, showed stronger C-MYB expression in the MYB-rearranged cases compared with other T-ALLs, and a dramatically skewed C-MYB allele expression in the TCRB-MYB cases, which suggests that a translocation-driven deregulated expression may overcome a cellular attempt to down-regulate C-MYB. Strikingly, profiling of the T-ALLs by clinical, genomic, and large-scale gene expression analyses shows that the TCRB-MYB translocation defines a new T-ALL subtype associated with a very young age for T-cell leukemia (median, 2.2 years) and with a proliferation/mitosis expression signature. By contrast, the MYBdup alteration was associated with the previously defined T-ALL subtypes.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||